Immatics N.V.
NASDAQ:IMTXBiotechnology
+$0.15 today
- Market cap
- $912.78M
- Beta
- 1.30
- P/E (TTM)
- -5.3
- EPS (TTM)
- -$1.59
Volume 1.57M
Average 0.46M
IMTX Operating Cash Flow
Cash generated by the company's core business operations during the period.
Immatics N.V.NASDAQ: IMTX
Operating Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Operating cash flow growth accelerates
Q1 FY2026 operating cash flow of €42.73M (cash outflow) rose 24.9% year over year, ahead of the +15.3% change in trailing-twelve-month operating cash flow. Sequentially, it fell 25.9% from the prior quarter.
Context
- Operating cash flow amounted to 351.5% of revenue in FY2025, up 250.1 pp from a year earlier.
- Operating cash flow increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +24.9% holds above the trailing-twelve-month pace of +15.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Operating Cash Flow history
EUR · from the cash flow
- Latest · FY2025
- (169.66M) EUR
- Year-over-year change
- -7.4%
| Period | Period end | Operating Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (169.66M) | -7.4% |
| FY2024 | 2024-12-31 | (158.03M) | -967.0% |
| FY2023 | 2023-12-31 | 18.23M | -81.8% |
| FY2022 | 2022-12-31 | 100.13M | +222.4% |
| FY2021 | 2021-12-31 | (81.78M) | — |
Operating Cash Flow vs competitors
How IMTX compares with its peers on the latest reported figures
- Peers report in different currencies, so operating cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +15.3% is the 4th highest of 11, against a peer median of -11.6%.
- Operating cash flow amounts to 493.7% of revenue for IMTX, versus a peer median of 111.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | €736.83M EUR | +139.2% | -68.2% | 27.9% | |
| LTM Sep 2026 | $247.8M USD | +45.7% | -20.7% | 18.2% | |
| LTM Mar 2026 | €184.13M EUR | +15.3% | — | 493.7% | |
| LTM Mar 2026 | $133.8M USD | -23.6% | -4.0% | 431600.0% | |
| LTM Mar 2026 | $122.01M USD | +2.4% | +26.7% | 1335.5% | |
| LTM Mar 2026 | $109.23M USD | -44.6% | -12.2% | — | |
| LTM Mar 2026 | $77.55M USD | +68.6% | +24.2% | 358.8% | |
| LTM Mar 2026 | $58.73M USD | +0.4% | +12.9% | 130.3% | |
| LTM Mar 2026 | $37.91M USD | -230.1% | -22.9% | 55.7% | |
| LTM Mar 2026 | $25.88M USD | -61.5% | -42.7% | 111.8% | |
| LTM Mar 2026 | $24.9M USD | -180.1% | -45.5% | 6.5% | |
| Peer median (excluding IMTX) | — | -11.6% | -16.4% | 111.8% | |
Competitors are the stored peer set for IMTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (93.34M) | 37.51M | (94.65M) | 15.22M | (188.69M) |
| Depreciation & Amortization | 5.26M | 6.97M | 7.23M | 12.23M | 11.91M |
| Deferred Income Tax | 11.15M | 4.52M | 0 | 6.13M | 0 |
| Stock-Based Compensation | 26.4M | 22.57M | 20.71M | 17.64M | 0 |
| Change in Working Capital | (31.7M) | 37.26M | 81.63M | (163.88M) | (42.23M) |
| Accounts Receivables | 569K | (429K) | (2.98M) | (1.76M) | (232.45K) |
| Inventory | 0 | 0 | (84.24M) | 0 | 0 |
| Accounts Payables | (31.78M) | 45.56M | 84.24M | 0 | (36.13M) |
| Other Working Capital | (483K) | (7.87M) | 84.61M | (162.11M) | (5.87M) |
| Other Non-Cash Items | 433K | (8.7M) | 3.31M | (45.37M) | 49.36M |
| Operating Cash Flow | (81.78M) | 100.13M | 18.23M | (158.03M) | (169.66M) |
| Capital Expenditures | (5.66M) | (6.22M) | (30.96M) | (16.48M) | (6.3M) |
| Acquisitions (Net) | 551K | (199.91M) | 0 | 0 | 0 |
| Purchases of Investments | (11.3M) | (216.32M) | (415.33M) | (450.35M) | (324.92M) |
| Sales of Investments | 24.45M | 12.7M | 414.74M | 314.44M | 528.16M |
| Other Investing Activities | (551K) | 199.96M | (8K) | (206K) | 0 |
| Investing Cash Flow | 7.49M | (209.79M) | (31.39M) | (152.39M) | 196.7M |
| Debt Repayment | (2.71M) | (2.84M) | (3.85M) | (2.01M) | 0 |
| Common Stock Issued | 94K | 134.48M | 90.4M | 343.01M | 96.35M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (7.93M) | (2.04M) | (21.31M) | (2.84M) |
| Financing Cash Flow | (2.61M) | 123.71M | 84.52M | 319.68M | 93.51M |
| Effect of Forex Changes | 2.37M | 1.48M | (1.4M) | 9.01M | 16.56M |
| Net Change in Cash | (74.54M) | 15.53M | 69.95M | 18.28M | 137.12M |
| Free Cash Flow | (87.44M) | 93.92M | (12.73M) | (174.51M) | (175.95M) |
Immatics N.V.
NASDAQ:IMTX
Intrinsic Alpha fair value
Locked
Current Price
$6.10
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.